280 related articles for article (PubMed ID: 33639868)
21. Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.
Talungchit S; Buajeeb W; Lerdtripop C; Surarit R; Chairatvit K; Roytrakul S; Kobayashi H; Izumi Y; Khovidhunkit SP
BMC Oral Health; 2018 Mar; 18(1):42. PubMed ID: 29534707
[TBL] [Abstract][Full Text] [Related]
22. Serum and salivary interleukin-4 levels in patients with oral lichen planus: A systematic review and meta-analysis.
Mozaffari HR; Zavattaro E; Saeedi M; Lopez-Jornet P; Sadeghi M; Safaei M; Imani MM; Nourbakhsh R; Moradpoor H; Golshah A; Sharifi R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Aug; 128(2):123-131. PubMed ID: 31097393
[TBL] [Abstract][Full Text] [Related]
23. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Hema Shree K; Ramani P; Sherlin H; Sukumaran G; Jeyaraj G; Don KR; Santhanam A; Ramasubramanian A; Sundar R
Pathol Oncol Res; 2019 Apr; 25(2):447-453. PubMed ID: 30712193
[TBL] [Abstract][Full Text] [Related]
24. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
25. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
[TBL] [Abstract][Full Text] [Related]
26. Salivary β2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma.
Nosratzehi F; Nosratzehi T; Alijani E; Rad SS
BMC Res Notes; 2020 Jun; 13(1):294. PubMed ID: 32552881
[TBL] [Abstract][Full Text] [Related]
27. [Levels of interlukin-6 and tumor necrosis factor-α in saliva of patients with type 2 diabetes mellitus and oral lichen planus].
Liu Y; Jin JQ; Yuan ZF; Liu XS; Cao J; Guo XH; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):596-9. PubMed ID: 21844975
[TBL] [Abstract][Full Text] [Related]
28. Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission.
Cheng YS; Rees T; Jordan L; Oxford L; O'Brien J; Chen HS; Wong D
Oral Oncol; 2011 Dec; 47(12):1122-6. PubMed ID: 21868280
[TBL] [Abstract][Full Text] [Related]
29. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects.
Katakura A; Kamiyama I; Takano N; Shibahara T; Muramatsu T; Ishihara K; Takagi R; Shouno T
Bull Tokyo Dent Coll; 2007 Nov; 48(4):199-203. PubMed ID: 18360107
[TBL] [Abstract][Full Text] [Related]
30. Salivary and serum levels of tumor necrosis factor-alpha in oral lichen planus: a systematic review and meta-analysis study.
Mozaffari HR; Ramezani M; Mahmoudiahmadabadi M; Omidpanah N; Sadeghi M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):e183-e189. PubMed ID: 28823317
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
Kaur J; Jacobs R
J Korean Assoc Oral Maxillofac Surg; 2015 Aug; 41(4):171-5. PubMed ID: 26339574
[TBL] [Abstract][Full Text] [Related]
32. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case-Control Study.
López-Jornet P; Olmo-Monedero A; Peres-Rubio C; Pons-Fuster E; Tvarijonaviciute A
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958429
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - A systematic review.
Piyarathne NS; Rasnayake RMSGK; Angammana R; Chandrasekera P; Ramachandra S; Weerasekera M; Yasawardene S; Abu-Eid R; Jayasinghe JAP; Gupta E
Expert Rev Mol Diagn; 2021 Aug; 21(8):789-807. PubMed ID: 34148471
[TBL] [Abstract][Full Text] [Related]
34. Advancements in diagnosing oral potentially malignant disorders: leveraging Vision transformers for multi-class detection.
Vinayahalingam S; van Nistelrooij N; Rothweiler R; Tel A; Verhoeven T; Tröltzsch D; Kesting M; Bergé S; Xi T; Heiland M; Flügge T
Clin Oral Investig; 2024 Jun; 28(7):364. PubMed ID: 38849649
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
36. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer.
Brailo V; Vucicevic-Boras V; Lukac J; Biocina-Lukenda D; Zilic-Alajbeg I; Milenovic A; Balija M
Med Oral Patol Oral Cir Bucal; 2012 Jan; 17(1):e10-5. PubMed ID: 21743397
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Salivary Level of Cortisol in Patients with Oral Lichen Planus: A Meta-Analysis.
Lopez-Jornet P; Zavattaro E; Mozaffari HR; Ramezani M; Sadeghi M
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137861
[No Abstract] [Full Text] [Related]
38. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
39. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
40. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
